Page last updated: 2024-09-03
l 658758 and lodelaben
l 658758 has been researched along with lodelaben in 1 studies
Compound Research Comparison
| Studies (l 658758) | Trials (l 658758) | Recent Studies (post-2010) (l 658758) | Studies (lodelaben) | Trials (lodelaben) | Recent Studies (post-2010) (lodelaben) |
|---|---|---|---|---|---|
| 26 | 0 | 0 | 6 | 0 | 0 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Davies, P; Dorn, C; Finke, P; Hanlon, WA; Humes, JL; Mumford, RA; Pacholok, SG | 1 |
Other Studies
1 other study(ies) available for l 658758 and lodelaben
| Article | Year |
|---|---|
Formation of polymorphonuclear leukocyte elastase: alpha 1 proteinase inhibitor complex and A alpha (1-21) fibrinopeptide in human blood stimulated with the calcium ionophore A23187. A model to characterize inhibitors of polymorphonuclear leukocyte elasta
Topics: alpha 1-Antitrypsin; Calcimycin; Cephalosporins; Chlorobenzoates; Dose-Response Relationship, Drug; Fibrin Fibrinogen Degradation Products; Humans; In Vitro Techniques; Leukocyte Elastase; Neutrophils; Oligopeptides; Pancreatic Elastase; Pyrrolidines | 1995 |